Clinical Trial Update: A Clinical Trial to Evaluate the Initial Safety and Efficacy of Repetitive BBB (Blood Brain Barrier) Disruption Using High Intensity Focused Ultrasound 'ExAblate 4000 Type 2.1' in Patients With Alzheimer's Disease [NA]

View source ↗

Summary

A not-yet-recruiting study evaluating the safety and initial efficacy of repetitive blood-brain barrier disruption using high-intensity focused ultrasound (ExAb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Alzheimer Disease | NA | Status: NOT_YET_RECRUITING